With the completion of the Human Genome Project and the arrival of the Post-Genomics Era, knowing age, gender and health status for prescribing medication is far from enough. The body's response to drugs (i.e. efficacy, metabolic and side effects) differs between individuals, creating a great blind spot and sense of insecurity without knowing a person's genetic information. Genetic variation is a fundamental factor in the emergence of any phenotypic changes and responsible for individual differences in drug responses. Use of advanced sequencing technology to assess drug response-associated genes (encoding drug metabolizing enzymes, transporters and receptors) allows for accurate individual drug treatment. The clinician can implement a dosing regimen tailoring to your genotypic data and offer rational drug use while minimizing side effects. Our combination of pharmacogenomics and clinical drug therapy aims to reduce your struggle and financial burden on unnecessary medication, as well as offers more effective personalised medical care.
CBT GeneHealth precision drug screening assesses the pharmacokinetics and pharmacodynamics of each drug type used to treat cardiovascular, cerebrovascular, neurological, immunoreactive and digestive problems, tumour chemotherapy and many more. Pharmacokinetic properties include the rate of absorption, distribution, metabolism of that drug and its excretion. Pharmacodynamics surrounds the efficacy of the drug and its related side effects. Significant gene mutations that may cause changes in any of the properties mentioned will also be assessed for drug selection optimization, dose adjustment as well as to provide precise individual drug recommendations.